Deplatt Tablets / Film-coated
Clopidogrel
75mg
Torrent Pharmaceutical Ltd.
| Pack size | 100's (10's Blister x 10) |
|---|---|
| Dispensing mode | POM |
| Source | INDIA |
| Agent | BETA STAR |
| Retail Price | 424.50 AED |
Available as:
Indications
Deplatt Tablets / Film-coated is used for:
Coronary Artery Disease, Acute coronary syndrome, Myocardial infarction, Peripheral vascular disease, Cerebrovascular disease, Atherosclerosis, Thromboembolic disorders, Unstable angina, Stroke
Adult Dose
Oral
Prophylaxis of thromboembolic disorders, Recent MI, Stroke, or Established Peripheral Arterial Disease, Coronary Artery Disease
Adult: 75 mg once daily.
Acute coronary syndrome
Adult: For ST-elevation MI: In combination w/ aspirin: 75 mg once daily.
<75 years
300 mg loading dose followed by 75 mg for 14 days up to 12 months (if no bleeding)
Concomitant therapy with aspirin: Administer in combination with aspirin 75-325 mg qDay with or without thrombolytics
>75 years
No loading dose
75 mg for 14 days up to 12 months (if no bleeding)
For unstable angina, non-ST-elevation MI: In combination w/ aspirin: Initially, 300 mg loading dose, followed by 75 mg once daily for up to 12 mth.
Hepatic impairment: Use caution; experience limited
Child Dose
Renal Dose
Renal impairment: Dose adjustment not necessary
Administration
May be taken with or without food.
Contra Indications
Hypersensitivity. Active pathological bleeding. admin within 7 days after MI and ischaemic stroke, coagulation disorders. Lactation.
Precautions
Patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; ulcer; renal and hepatic impairment; history of bleeding or haemostatic disorders. Pregnancy.
Lactation: Not known whether drug is excreted in breast milk; not recommended
Pregnancy-Lactation
Pregnancy
Available data from cases reported over two decades in published literature and postmarketing surveillance have not identified any drug-associated risks for major birth defects or miscarriage; there are risks to pregnant woman and fetus associated with myocardial infarction and stroke
Myocardial infarction and stroke are medical emergencies; therapy for pregnant woman should not be withheld because of potential concerns regarding effects of clopidogrel on the fetus
Labor or delivery
Therapy during labor or delivery will increase risk of maternal bleeding and hemorrhage; avoid neuraxial blockade during clopidogrel use because of risk of spinal hematoma; when possible, discontinue therapy 5-7 days prior to labor, delivery, or neuraxial blockade
There are no data on presence of drug in human milk or effects on milk production; no adverse effects on breastfed infants observed during lactation in a small number of postmarketing cases; studies in rats have shown that clopidogrel and/or its metabolites are present in milk; when a drug is present in animal milk, it is likely that the drug will be present in human milk; consider developmental and health benefits of breastfeeding along with mother’s clinical need for therapy and any potential adverse effects on breastfed infant from drug or underlying maternal condition
Interactions
Co-admin with NSAIDs may increase the risk of stomach and intestinal bleeding. High-dose clopidogrel may lead to increased warfarin levels thus increasing the risk of bleeding. High-dose clopidogrel may also inhibit P450 (2C9), thus interfering with the metabolism of phenytoin, tamoxifen, torasemide, fluvastatin and some NSAIDs. Avoid c
Adverse Effects
Side effects of Clopidogrel :
1-10%
Upper respiratory tract infection (8.7%), Chest pain (8.3%), Headache (7.6%), Flulike syndrome (7.5%), Arthralgia (6%), Pain (6%), Dizziness (6%), Diarrhea (4.5%), Rash (4.2%), Rhinitis (4.2%), Depression (3.6%), Urinary tract infection (3.1%)
<1%
Severe neutropenia, Thrombotic thrombocytopenic purpura, Acute liver failure, Aplastic anemia, Hypotension, Hepatitis, Myalgia, Eczema, Erythema, Agranulocytosis
Potentially Fatal: Bleeding disorders including GI and intracranial haemorrhage. Blood dyscrasias.
Mechanism of Action
Clopidogrel inhibits adenosine diphosphate (ADP) from binding to its receptor sites on the platelets and subsequent activation of glycoprotein GP IIb/IIIa complex thus preventing fibrinogen binding, platelet adhesion and aggregation.
Note
Deplatt 75mg Tablets / Film-coated manufactured by Torrent Pharmaceutical Ltd.. Its generic name is Clopidogrel. Deplatt is availble in United Arab Emirates.
Farmaco UAE drug index information on Deplatt Tablets / Film-coated is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Clopidogrel :
Tablets / Film-coated
Zygrel
75mg
Oman Pharmaceutical Products
Tablets / Film-coated
Thinrin
75mg
Neobiocon
Tablets / Film-coated
Plavix
75mg
Sanofi Winthrop Industrie
Tablets / Film-coated
Plavix
300mg
Sanofi Winthrop Industrie
Tablets / Film-coated
Pedovex
75mg
Tabuk Pharmaceutical Manufacturing Co.